Jamile M. Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Section of Hematology and Stem Cell Transplantation
Division of Hematology/Oncology
Rush University Medical Center
Chicago, Illinois

Dr. Jamile Shammo earned her medical degree from Aleppo Medical School in Syria, after which she sought further education in the US, and completed residencies in anatomic and clinical pathology, as well as internal medicine at McGaw Medical Center of Northwestern University, Evanston, Illinois. She then completed a 3-year fellowship in the Division of Hematology/Oncology at University of Chicago. Dr. Shammo is Professor of Medicine and Pathology, Section of Hematology and Stem Cell Transplantation, Division of Hematology/Oncology, at Rush University Medical Center in Chicago, Illinois, where she spearheads the MDS/MPN/Bone Marrow Failure Program. As principal investigator of clinical trials in her area of expertise, and as chair of the protocol review and monitoring committee at Rush Cancer Institute, Dr. Shammo is heavily involved in education, research, and administrative activities in the Division of Hematology/Oncology. She is recognized nationally for her expertise in bone marrow failure syndromes/PNH, and was chosen to serve in the role of a national coordinator for the US PNH registry.

Dr. Shammo is board certified in anatomic and clinical pathology as well as hematology, and is board eligible in internal medicine, and oncology. She is a fellow of both the American Society of Clinical Pathologists and American College of Physicians. She received the Department of Medicine Service and Teaching Award from Rush University Medical Center in 2003, and was a finalist in the Department of Medicine positive environment learning award in 2014. She founded the Chicago MDS/MPN group, and has chaired several educational events to facilitate scientific exchange between academic medical centers in Chicago. She has developed and chaired multiple online CME activities pertaining to MDS as well as MPN. Dr. Shammo has authored and contributed to more than 100 publications including abstracts, posters, and book chapters. Her articles have been published in Blood, American Journal of Hematology, Journal of Clinical Oncology, Clinical Lymphoma, Journal of Heart and Lung Transplantation, Cytotherapy, and American Journal of Clinical Pathology, among others. She served as a reviewer for several medical journals including Journal of Clinical Oncology. Dr. Shammo has designed and conducted several investigator-initiated trials, and is currently involved as principal investigator for many clinical trials related to chronic myelogenous leukemia, myeloproliferative neoplasms, paroxysmal nocturnal hemoglobinuria, and myelodysplastic syndromes. As an invited speaker, Dr. Shammo lectured at national and international meetings and conferences.

Last modified: March 3, 2020